Export

Bendamustine
Essential medicine status
General description
Bendamustine is a antineoplastic alkylating agent, used in the treatment of chronic lymphocytic leukaemia and follicular lymphoma.
INN
Bendamustine
Medicine type
Chemical agent
EML status history
Wikipedia
Recommendations
Section
Cytotoxic medicines
  • Parenteral > General injections > unspecified: 45 mg per 0.5 mL; 180 mg per 2 mL